Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

Environmental Determinants of Type 1 Diabetes Risk — RECRUITING. Locations: Changsha, Hunan, China. To analyze the environmental risk factors for type 1 diabetes in China.Source
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus — RECRUITING, PHASE2. Interventions: Rezpegaldesleukin, Placebo. Locations: San Francisco, California, United States | Aurora, Colorado, United States | New Haven, Connecticut, United States. This Phase 2 study is a 2-arm...Source
INNODIA Family & Friends Early-Stage T1D Detection Protocol — RECRUITING. Locations: Vienna, Austria | Leuven, Belgium | Prague, Czechia. The purpose of INNODIA DETECT is to identify people who are at increased risk of developing T1D. Investigators are doing this by testing for ma...Source
Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children — RECRUITING. Interventions: MAIT cells analysis, MAIT cytokines production analysis, Lactulose/Mannitol Test. Locations: Antony, France | Paris, France. To investigate in a prospective way changes in Mucosal-Associated I...Source
INfluenza VaccInation To Mitigate typE 1 Diabetes — RECRUITING, PHASE4. Interventions: Vaxigrip Tetra Sanofi Pasteur Europe. Locations: Aalborg, Denmark | Aarhus, Denmark | Copenhagen, Denmark. In a multicenter, prospective, randomized, controlled clinical trial to compa...Source
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes — RECRUITING, PHASE3. Interventions: Aspirin tablet, Semaglutide, Sotagliflozin. Locations: Copenhagen, Denmark | Herlev, Denmark. A prospective, randomised, open-labelled, multi-center study. The aim of the Steno 1 study...Source
Effect of Circadian Rhythm and Physical Exercise in Overweight Type 1 Diabetes Patients — RECRUITING, NA. Interventions: High intensity interval training (HIIT). Locations: Stockholm, Sweden. Cardiometabolic risk in patients with abdominal obesity and type 1 diabetes can be moderated by life style modificati...Source

Questions before contacting a study

Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.